Podcasts about triple negative breast cancer

On this episode: ⁃ Lawson high School hosted the 3rd annual Hoops for Hope in a great day of girls basketball while also raising money and awareness towards Triple Negative Breast Cancer. ⁃ Monday Scoreboard Wanna thank all of our great Sponsors who make all of this possible.Tolly & Associates Little Caesars of St. Joseph John Anderson Insurance, Meierhofer Funeral Home & Crematory HiHo Bar & Grill Barnes Roofing Jayson & Mary Watkins Matt & Jenni Busby Michelle Cook Group Russell Book & Bookball 365 The St. Joseph MustangsB's Tees KT Logistics LLC Hixson-Klein Funeral Home James L. Griffith Law Firm of Maysville Toby Prussman of Premier Land & Auction Group, HK Quality Sheet Metal, Redman Farms of Maysville, Melissa WinnHenke Farms, Green Hills Insurance LLC., Cintas, Thrive Family Chiropractic, IV Nutrition of St. Joseph, Roth Kid Nation Serve Link Home Care out of Trenton, Barnett's Floor Renewal LLC., Balloons D'Lux, B3 Renovations, The Hamilton Bank member FDIC, Wompas Graphix & Embroidery of LibertyEllis Sheep Company of Maysville, Bank Northwest of Cameron, Akey's Catering & Event Rentals, Brown Bear of St. Joseph, Whitney Whitt Agency of Hamilton, Wolf Black Herefords, The KCI Basketball Podcast Jacob Erdman - Shelter Insurance of Rock Port, Rob & Stacia Studer, Green Family Chiropractic , Annie & Noah Roseberry of Re/Max Professionals, Moseley Farms, Jake Anderson of Shelter Insurance Bray Farms of Cameron.A slice & a swirl of Maysville Adkison Barber ShopMoyer Concrete of Maysville Cody Vaughn Wealth Advisor with ThriventGallatin Truck & Tractor Grandmas Gun Shop in Agency Nash Gas in Dearborn Accurate Appraisal in St. Joseph Ryan Meyerkorth SeedB.W. Timber of Bethany Mosaic Medical Center of Maryville Exclusive P.R. of Chicago Great Than Financial Hogue Lumber Company of Albany Stifel in ChillicotheUnited Cooperates, INC out of Osborn & Pattonsburg MP and Sons Contracting in Maysville JA White Construction in Maysville BTC Bank Seth & Marcie Davis of the Fitz Group Home and LandGRM Networks Perry Plumming & Septic LLC of Rock PortCitizens Bank and Trust of Rock Port C&M Business Machines Deal Travel and Cruises LLC

Lindsay Gustafson was just 38 years old when she was diagnosed with Stage 2 triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease. For two years, she endured conventional treatment. Then, in June 2024, everything changed. Scans revealed the cancer had spread to her lung, escalating her diagnosis to Stage 4. That moment marked a turning point, leading Lindsay to Corrie and to a cannabis protocol that would soon become central to her healing. Visit our website: CannabisHealthRadio.com Find high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealth Discover products and get expert advice from Swan Apothecary Follow us on Facebook. Follow us on Instagram. Find us on Rumble. Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Host: Ryan Quigley Triple-negative breast cancer (TNBC) remains one of the hardest subtypes to treat, with limited options and high relapse rates—so identifying new therapeutic targets is critical. In this AudioAbstract, Ryan Quigley spotlights research presented at the San Antonio Breast Cancer Symposium that implicates ribosome biogenesis as a key vulnerability. Tune in to learn how this approach could inform the next generation of TNBC therapies.

Host: Ryan Quigley Triple-negative breast cancer (TNBC) remains one of the hardest subtypes to treat, with limited options and high relapse rates—so identifying new therapeutic targets is critical. In this AudioAbstract, Ryan Quigley spotlights research presented at the San Antonio Breast Cancer Symposium that implicates ribosome biogenesis as a key vulnerability. Tune in to learn how this approach could inform the next generation of TNBC therapies.

Featuring perspectives from Prof Giuseppe Curigliano and Dr Priyanka Sharma, including the following topics: HER2-Positive Breast Cancer (0:00) Hormone Receptor-Positive Breast Cancer (18:16) Triple-Negative Breast Cancer (1:05:23) CME information and select publications

Dr. Andrei Goga and his colleagues found that triple-negative breast cancer cells build molecular tunnels called gap junctions into nearby fat cells and use the fat cells' energy for fuel. When the scientists blocked the gap junctions, the tumors stopped growing. Listen to the episode to hear Dr. Goga explain: how the study came about how the cancer cells connect to the fat cells how the process could work in metastatic TNBC what the results could mean for treating triple negative disease.

Dr. Jay Lalezari, CEO of CytoDyn, is focused on solid tumor immunology, particularly in triple-negative breast cancer, where their lead drug, leronlimab, is showing significant long-term survival benefits.  This monoclonal antibody targets the CCR5 receptor, converting cold tumors into hot tumors and making them more susceptible to immunotherapy checkpoint inhibitors. Work with leronlimab for 20 years has demonstrated the potential for use in colorectal cancer as well as TNBC, and to vastly expand the patient population that could benefit from immunotherapy. Jay explains, "When I became CEO back in November of 2023, my first order of business was to figure out where CytoDyn should go with this intriguing monoclonal antibody called leronlimab that targets CCR5. And we looked at a number of indications, and by far and away, the data that we found in solid tumor oncology is clearly the place CytoDyn will go to create the most benefit for patients and the most benefit for our shareholders. We recently presented some data in triple-negative breast cancer that is truly remarkable and potentially paradigm-shifting in the world of solid tumor oncology."   "Over the years, it became clear that CCR5 was not just for the virus to get inside the cell, but was playing a key role in setting up the tumor microenvironment in a variety of solid tumors that were CCR5 positive. That included typically triple-negative breast cancer, colon cancer, prostate cancer, pancreatic cancer, sarcoma, glioblastoma, and the urothelial cancers in particular. So CCR5 helps the cancer set up a tumor microenvironment that helps it both build blood vessels to provide nourishment for the cancer and attract suppressor cells that keep the host immune system at bay."  #CytoDyn #Oncology #Leronlimab #TNBC #ColorectalCancer #CCR5 cytodyn.com Download the transcript here

Dr. Jay Lalezari, CEO of CytoDyn, is focused on solid tumor immunology, particularly in triple-negative breast cancer, where their lead drug, leronlimab, is showing significant long-term survival benefits.  This monoclonal antibody targets the CCR5 receptor, converting cold tumors into hot tumors and making them more susceptible to immunotherapy checkpoint inhibitors. Work with leronlimab for 20 years has demonstrated the potential for use in colorectal cancer as well as TNBC, and to vastly expand the patient population that could benefit from immunotherapy. Jay explains, "When I became CEO back in November of 2023, my first order of business was to figure out where CytoDyn should go with this intriguing monoclonal antibody called leronlimab that targets CCR5. And we looked at a number of indications, and by far and away, the data that we found in solid tumor oncology is clearly the place CytoDyn will go to create the most benefit for patients and the most benefit for our shareholders. We recently presented some data in triple-negative breast cancer that is truly remarkable and potentially paradigm-shifting in the world of solid tumor oncology."   "Over the years, it became clear that CCR5 was not just for the virus to get inside the cell, but was playing a key role in setting up the tumor microenvironment in a variety of solid tumors that were CCR5 positive. That included typically triple-negative breast cancer, colon cancer, prostate cancer, pancreatic cancer, sarcoma, glioblastoma, and the urothelial cancers in particular. So CCR5 helps the cancer set up a tumor microenvironment that helps it both build blood vessels to provide nourishment for the cancer and attract suppressor cells that keep the host immune system at bay."  #CytoDyn #Oncology #Leronlimab #TNBC #ColorectalCancer #CCR5 cytodyn.com Listen to the podcast here

Rosa was diagnosed in March 2019 with Triple negative Breast Cancer. She chose alternative therapies from the beginning including Zhineng QiGong. Then in January 2021 an ultrasound revealed no more metabolic activity. Rosa followed all of the RR healing factors and found that they were all essential. Today, Rosa practices Homeopathic medicine, Hakomi and EFT, as well as psycho-body centered therapies and Shamanic Healing.  Rosa can be reached via WhatsApp +52-77-198-2553 or by email: rosa.belendez@gmail.com link to Karla's interview Nov 2023 ___________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com.   To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube _______________

- Overview of Metastatic Triple Negative Breast Cancer - The Important Role of the Caregiver in Communicating with the Health Care Team - Your Important Role in Decision Making - Taking on the Role of Caregiving - What Research Tells Us About Caregivers - Caregiving for Your Loved One with Metastatic Triple Negative Breast Cancer - Challenges in Communicating with the Health Care Team - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Prepared List of Questions, Quality-of-Life Concerns, Discussion of OpenNotes & Follow-Up Appointments - Coping with Each Day, On Special Occasions, Holidays & Birthdays - Managing Family & Friends - Long Distance Caregiving - Self-Care & Stress Management Recommendations to Manage the Stress of Caregiving - Questions for Our Panel of Experts

- Overview of Metastatic Triple Negative Breast Cancer - The Important Role of the Caregiver in Communicating with the Health Care Team - Your Important Role in Decision Making - Taking on the Role of Caregiving - What Research Tells Us About Caregivers - Caregiving for Your Loved One with Metastatic Triple Negative Breast Cancer - Challenges in Communicating with the Health Care Team - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Prepared List of Questions, Quality-of-Life Concerns, Discussion of OpenNotes & Follow-Up Appointments - Coping with Each Day, On Special Occasions, Holidays & Birthdays - Managing Family & Friends - Long Distance Caregiving - Self-Care & Stress Management Recommendations to Manage the Stress of Caregiving - Questions for Our Panel of Experts

- Overview of Metastatic Triple Negative Breast Cancer - The Important Role of the Caregiver in Communicating with the Health Care Team - Your Important Role in Decision Making - Taking on the Role of Caregiving - What Research Tells Us About Caregivers - Caregiving for Your Loved One with Metastatic Triple Negative Breast Cancer - Challenges in Communicating with the Health Care Team - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Prepared List of Questions, Quality-of-Life Concerns, Discussion of OpenNotes & Follow-Up Appointments - Coping with Each Day, On Special Occasions, Holidays & Birthdays - Managing Family & Friends - Long Distance Caregiving - Self-Care & Stress Management Recommendations to Manage the Stress of Caregiving - Questions for Our Panel of Experts

New research presented at ESMO 2025 confirms that datopotamab deruxtecan significantly improves progression-free and overall survival compared with chemotherapy in advanced triple-negative breast cancer, supporting its role as a first-line standard of care. Updated SELECT trial analyses demonstrate that semaglutide reduces major cardiovascular events by 20% independent of weight loss, suggesting cardioprotective mechanisms beyond adiposity reduction. Long-term data show that HPV vaccination has led to dramatic declines in vaccine-type infections and strong herd protection, although global coverage remains suboptimal.

Janice Cowden, retired nurse and patient advocate, shares her remarkable triple negative breast cancer (TNBC) story. Five years following successful treatment for stage one breast cancer in 2011, Janice was diagnosed with a stage 4 metastatic TNBC recurrence. As of today she has 8 years of no evidence of disease (NED) under her belt. She shares how she stumbled upon the cancer community that inspired her to become the advocate she is today and the uncertainty that comes with NED. She also shares how she copes with losing friends in the cancer community through her patient advocacy work. We also have a rapid fire Q&A where she answers questions surrounding various medical terminologies, diagnoses, and more to keep you in the loop. NOTE: There is one clarification from the rapid fire Q&A session. The definition of disease free survival (DFS) is the time from random assignment (used in clinical trials and research studies to assign participants to different groups) to cancer recurrence or death from any cause (Gutman SI, Piper M, Grant MD, et al. 2013).Key Highlights:1. Metastatic breast cancer (MBC) is stage four breast cancer that has spread to distant sites in the body.2. Finding events and communities centered around cancer not only supports cancer patients emotionally and socially, but can also serve as informational hubs. Being proactive in learning about your diagnosis, whether it's through community and/or research on your own time, can help you feel confident with the choices you make. 3. While finding a community of other cancer patients can help, unfortunately this disease means that you will lose friends you make in these settings. It doesn't necessarily get easier, but finding an outlet to cope with such losses is vital to your wellbeing.About our guest:Diagnosed with Stage IV triple negative breast cancer in 2016, five years after an early-stage breast cancer diagnosis, Janice launched into patient advocacy following training through Living Beyond Breast Cancer's (LBBC) Hear My Voice Outreach program in 2017. As a peer-to-peer support and research patient advocate, Janice is passionate about supporting others with metastatic breast cancer, in addition to continually furthering her scientific knowledge base of this disease, treatments, and clinical trials, which she acquires through attending scientific breast cancer conferences and webinars. Janice is involved with several patient-founded and led organizations including PCDI, GRASP, and Project Life MBC. As a trained peer support volunteer, she is founder of an international online peer support group for patients newly diagnosed with MBC. She serves on the Board of Directors for METAvivor Research and Support Inc., and is an Advisory Board member for Project Life MBC. She is an individual member of the Metastatic Breast Cancer Alliance. When she's not busy with advocacy work, Janice enjoys traveling, reading, outdoor activities, and spending time with family, including her husband, two adult children and three grandchildren.Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions.

- Updates on the Treatment of Metastatic Triple Negative Breast Cancer - Novel Treatment Therapies - Clinical Trial Updates - How Research Offers Additional Treatment Options - Biomarkers, Diagnostic Testing & Genomics: Why They Are So Important - The Role of Precision Medicine in Improving Treatment Decisions - Sequencing of Treatments - Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Key Questions to Ask Your Health Care Team, Including Lifestyle & Quality-of-Life Concerns - Practical Strategies to Cope with Metastatic Triple Negative Breast Cancer - How to Find the Financial, Emotional & Social Supports to Cope - Questions for Our Panel of Experts

- Updates on the Treatment of Metastatic Triple Negative Breast Cancer - Novel Treatment Therapies - Clinical Trial Updates - How Research Offers Additional Treatment Options - Biomarkers, Diagnostic Testing & Genomics: Why They Are So Important - The Role of Precision Medicine in Improving Treatment Decisions - Sequencing of Treatments - Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Key Questions to Ask Your Health Care Team, Including Lifestyle & Quality-of-Life Concerns - Practical Strategies to Cope with Metastatic Triple Negative Breast Cancer - How to Find the Financial, Emotional & Social Supports to Cope - Questions for Our Panel of Experts

- Updates on the Treatment of Metastatic Triple Negative Breast Cancer - Novel Treatment Therapies - Clinical Trial Updates - How Research Offers Additional Treatment Options - Biomarkers, Diagnostic Testing & Genomics: Why They Are So Important - The Role of Precision Medicine in Improving Treatment Decisions - Sequencing of Treatments - Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Key Questions to Ask Your Health Care Team, Including Lifestyle & Quality-of-Life Concerns - Practical Strategies to Cope with Metastatic Triple Negative Breast Cancer - How to Find the Financial, Emotional & Social Supports to Cope - Questions for Our Panel of Experts

- Overview of Triple Negative Breast Cancer - The Difference in Triple Negative Breast Cancer for Black/African American Women - Triple Negative Breast Cancer & African American Women - The Role of Surgery - Precision Medicine & Treatment Sequencing - Current Standard of Care - New Treatment Approaches - Clinical Trial Updates - How Clinical Trial Participation Contributes to Treatment Options - Tips to Manage Treatment Side Effects, Symptoms, Neuropathy, Discomfort & Pain - Follow-Up Care Plan - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Follow-Up Appointments - Questions for Our Panel of Experts

- Overview of Triple Negative Breast Cancer - The Difference in Triple Negative Breast Cancer for Black/African American Women - Triple Negative Breast Cancer & African American Women - The Role of Surgery - Precision Medicine & Treatment Sequencing - Current Standard of Care - New Treatment Approaches - Clinical Trial Updates - How Clinical Trial Participation Contributes to Treatment Options - Tips to Manage Treatment Side Effects, Symptoms, Neuropathy, Discomfort & Pain - Follow-Up Care Plan - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Follow-Up Appointments - Questions for Our Panel of Experts

- Overview of Triple Negative Breast Cancer - The Difference in Triple Negative Breast Cancer for Black/African American Women - Triple Negative Breast Cancer & African American Women - The Role of Surgery - Precision Medicine & Treatment Sequencing - Current Standard of Care - New Treatment Approaches - Clinical Trial Updates - How Clinical Trial Participation Contributes to Treatment Options - Tips to Manage Treatment Side Effects, Symptoms, Neuropathy, Discomfort & Pain - Follow-Up Care Plan - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Follow-Up Appointments - Questions for Our Panel of Experts

In this heartfelt conversation, Tonya Combest shares her journey through a breast cancer diagnosis, treatment, and recovery. She discusses the emotional challenges, the importance of community support, and the role of financial planning in navigating her health crisis. Tonya emphasizes the significance of self-exams, the need for reliable medical advice, and the power of empathy in connecting with others facing similar battles. Her story is one of resilience, hope, and the determination to live life fully after cancer.Born and raised in Lubbock, Texas, she and her husband Kevin built a compassionate family business, Combest Family Funeral Homes, serving their community with care. Despite facing a late Stage 3 Triple Negative Breast Cancer diagnosis in 2021, Tonya's strength and faith saw her through rigorous treatments and recovery. Today, she is cancer-free and continues to support others facing similar challenges. Her extensive experience in funeral services and hospice care, combined with her personal journey, makes her an inspiring podcast guest. Join us to hear Tonya's story of overcoming adversity and her insights on community service and end-of-life care.Combest Family Funeral Homes & Crematory | Lubbock, TXTonya Bowen Combest | FacebookGet In Touch With Tonya:

This is a bonus episode of the audio of a Breastcancer.org ⁠⁠⁠⁠webinar⁠⁠⁠⁠. Triple-negative breast cancer (TNBC) is an invasive subtype of breast cancer that can be harder to treat and is more likely to come back. But new research into understanding TNBC is helping some patients find more precise treatment options.  Learn about innovations in immunotherapy, genetic testing, and targeted therapies, why TNBC is different compared to other types of breast cancer, and what gives doctors hope about the future of care for people with TNBC. You'll also hear from two inspiring breast cancer advocates who created TNBC resources for patients after their own diagnosis. Read more about triple-negative breast cancer. Featured Speakers: Maimah KarmoBreast Cancer Advocate and Founder, Tigerlily Roberto Leon-Ferre, MDCo-Leader of the Triple-Negative Breast Cancer Working Group and Associate Professor at Mayo Clinic Evelyn Taiwo, MDHematology and Oncology at New York Presbyterian Brooklyn Methodist Hospital and Associate Professor at Cornell University Kelly ThomasBreast Cancer Advocate and Founder, TNBC Thrivers Marisa Weiss, MDChief Medical Officer, Breastcancer.org

Have a comment or question? Click this sentence to send us a message, and we might answer it in a future episode.Welcome to Season 5, Episode 34 of Winning Isn't Easy. In this episode, we'll dive into the complicated topic of "Breast Cancer and Disability - Understanding the Condition, Its Impact, and Your Claim."Most people assume that a breast cancer diagnosis automatically guarantees Long-Term Disability benefits, but in ERISA claims, it's rarely that simple. Insurance companies often downplay symptoms, ignore treatment side effects, or misclassify your job duties to deny or terminate benefits. The truth is, even early-stage breast cancer can cause lasting physical and cognitive challenges that make full-time work impossible, and your paperwork must tell that story clearly. In this episode of Winning Isn't Easy, disability law expert Nancy L. Cavey explains what it really takes to win a breast cancer Long-Term Disability claim. You'll learn how insurers evaluate cancer-related claims, what evidence they find persuasive, and how to document limitations such as fatigue, pain, cognitive changes, and immune issues so your claim stands strong. We'll also cover how your cancer stage, treatment plan, and occupation affect an insurer's decision, and share a real-world case where benefits were cut off too soon and what it took to fight back. If you or someone you love is facing breast cancer while protecting your financial future, this episode offers the knowledge, strategy, and confidence to take control of your claim. Because in disability law, telling your story the right way isn't just important - it's essential. Winning Isn't Easy, but with the right guidance, it can be done.In this episode, we'll cover the following topics:One - Breast Cancer and Its SymptomsTwo - How Breast Cancer Can Be DisablingThree - Case Example – Lessons From the Kiersman CaseWhether you're a claimant, or simply seeking valuable insights into the disability claims landscape, this episode provides essential guidance to help you succeed in your journey. Don't miss it.Listen to Our Sister Podcast:We have a sister podcast - Winning Isn't Easy: Navigating Your Social Security Disability Claim. Give it a listen: https://wiessdpodcast.buzzsprout.com/Resources Mentioned in This Episode:LINK TO ROBBED OF YOUR PEACE OF MIND: https://mailchi.mp/caveylaw/ltd-robbed-of-your-piece-of-mindLINK TO THE DISABILITY INSURANCE CLAIM SURVIVAL GUIDE FOR PROFESSIONALS: https://mailchi.mp/caveylaw/professionals-guide-to-ltd-benefitsFREE CONSULT LINK: https://caveylaw.com/contact-us/Need Help Today?:Need help with your Long-Term Disability or ERISA claim? Have questions? Please feel welcome to reach out to use for a FREE consultation. Just mention you listened to our podcast.Review, like, and give us a thumbs up wherever you are listening to Winning Isn't Easy. We love to see your feedback about our podcast, and it helps us grow and improve.Please remember that the content shared is for informational purposes only, and should not replace personalized legal advice or guidance from qualified professionals. 

Featuring perspectives from Dr Sara A Hurvitz and Dr Sara M Tolaney, including the following topics: Introduction: View from Outer Space (0:00) Hormone Receptor-Positive Breast Cancer (6:23) HER2-Positive Breast Cancer (40:54) Triple-Negative Breast Cancer (52:48) CME information and select publications

Featuring an interview with Prof Peter Schmid, including the following topics: Response to immunotherapy in breast cancer subtypes (0:00) Tolerability of TROP2 antibody-drug conjugates (ADCs) for metastatic breast cancer (mBC) (3:51) Approaches to therapy for patients with HR-negative HER2-low and HER2-ultralow mBC (13:03) ADC structure and treatment-related adverse events (19:02) Available data from the Phase III ASCENT-04 trial evaluating sacituzumab govitecan with pembrolizumab as first-line therapy for patients with PD-L1-positive advanced triple-negative breast cancer (23:06) Novel ADCs and bispecific antibodies under investigation for mBC (28:30) Comparing datopotamab deruxtecan and sacituzumab govitecan for HR-positive disease (33:01) Clinical investigator perspectives on the Phase III DESTINY-Breast09 trial evaluating first-line trastuzumab deruxtecan with or without pertuzumab versus THP (docetaxel/rastuzumab/pertuzumab) for HER2-positive mBC (35:06) CME information and select publications

Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer. CME information and select publications here.

Featuring a slide presentation and related discussion from Prof Peter Schmid, including the following topics: Evolution of the therapeutic landscape for metastatic triple-negative breast cancer; age of immunotherapy (0:00) Case: A woman in her early 40s with no actionable mutations (7:29) Evolution of antibody-drug conjugates (ADCs) in the management of metastatic breast cancer (11:13) TROP2-directed ADCs (15:22) Case: A woman in her early 50s with PD-L1-negative, HR-negative, HER2-low de novo metastatic breast cancer (20:21) Novel strategies utilizing approved and investigational ADCs (23:28) Case: A woman in her early 60s with loss of HER2 expression on disease progression (31:39) ADCs in combination with immunotherapy (32:51) CME information and select publications

Send us a text

Becca Johnson shares the sequence of events that led to her breast cancer diagnosis and what happened next. Initial mammograms and consultations showed no clear issues, but persistent symptoms led Becca to push for further testing. When the diagnosis came, she documented every detail and sought support from medical staff and loved ones. Becca describes communicating with her children and organizing her next steps. Faith guided her choices as she incorporated both conventional treatment and alternative approaches. Community support, including fundraising through T-shirt sales featuring meaningful Bible verses, helped cover medical expenses. Becca stresses the importance of research, questioning, and finding a supportive network. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. How did Becca Johnson first discover she had breast cancer? 2. What was Becca’s initial reaction upon receiving her cancer diagnosis? 3. How did Becca approach telling her children about her diagnosis? 4. What did Becca do after learning about her diagnosis? 5. What specific type of breast cancer was Becca diagnosed with? 6. Did Becca have any known familial risk factors for breast cancer? 7. How did Becca’s faith influence her journey with breast cancer? 8. What role did Becca’s support network play during her diagnosis and treatment? 9. What advice does Becca share for others who receive a cancer diagnosis? 10. What does Becca recommend to those struggling with feelings of isolation after a cancer diagnosis? 11. How did Becca personalize her healing journey (e.g., alternative treatments, lifestyle changes)? Timestamped Overview 00:00 Mammogram Misdiagnosis: Lingering Concerns 06:15 Urgent Call to Doctor 06:52 Seeking Guidance and Self-Discipline 12:11 A Life-Altering Diagnosis 16:04 Urgent Lumpectomy Needed 17:30 Surgery Decision Urgency 21:26 Exodus 14 Revelation 26:10 Spiritual Awakening at 25 27:10 Turning Point: A New Path 31:25 Unique Responses to Cancer TreatmentSee omnystudio.com/listener for privacy information.

Dr Ana C Garrido-Castro and Prof Peter Schmid review patient cases and provide insights regarding the treatment of metastatic triple-negative breast cancer. CME information and select publications here.

Featuring perspectives from Dr Ana C Garrido-Castro and Prof Peter Schmid, including the following topics:  Introduction: Legendary Figures in Breast Cancer Research (0:00) Case: A woman in her early 80s, a current smoker with a history of myocardial infarction and stroke, who develops recurrent triple-negative breast cancer (TNBC) — Justin Favaro, MD, PhD (6:44) Case: A woman in her late 60s with metastatic TNBC and a PD-L1 level of 20% who receives chemotherapy/pembrolizumab followed by sacituzumab govitecan — Priya Rudolph, MD, PhD (25:08) Case: A woman in her late 60s with localized TNBC who develops myocarditis while receiving neoadjuvant chemotherapy/pembrolizumab — Richard Zelkowitz, MD (33:53) Case: A woman in her mid 60s with recurrent ER-negative, HER2-low, PI3K-mutant TNBC — Ranju Gupta, MD (37:49) Case: A woman in her early 60s with recurrent TNBC confined to contralateral neck nodes — Eric H Lee, MD, PhD (42:10) Case: A woman in her early 40s with metastatic TNBC who receives sacituzumab govitecan after multiple lines of chemotherapy — Estelamari Rodriguez, MD, MPH (48:10) Case: A woman in her mid 70s with ER-negative, HER2-low breast cancer who develops an isolated brain metastasis — Dr Gupta (55:02) CME information and select publications

- Overview of Triple Negative Breast Cancer - Fear of Recurrence - Concerns That Cancer May Come Back - Events That May Trigger Fear of Recurrence: Living with Continuing Uncertainty - Promoting Effective Health Care Communication - Making Informed Treatment Choices - Follow-Up Care - Tips for Coping with Fear of Recurrence - Balancing Reality with Stress Management Tips - Using Mind Body Techniques to Cope with Fear of Recurrence - How to Select the Mind Body Techniques That are Best for You - Communicating with Your Health Care Team About Quality-of-Life & Lifestyles Concerns - Guidelines for Preparing for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & OpenNotes Discussion - Questions for Our Panel of Experts

- Overview of Triple Negative Breast Cancer - Fear of Recurrence - Concerns That Cancer May Come Back - Events That May Trigger Fear of Recurrence: Living with Continuing Uncertainty - Promoting Effective Health Care Communication - Making Informed Treatment Choices - Follow-Up Care - Tips for Coping with Fear of Recurrence - Balancing Reality with Stress Management Tips - Using Mind Body Techniques to Cope with Fear of Recurrence - How to Select the Mind Body Techniques That are Best for You - Communicating with Your Health Care Team About Quality-of-Life & Lifestyles Concerns - Guidelines for Preparing for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & OpenNotes Discussion - Questions for Our Panel of Experts

- Overview of Triple Negative Breast Cancer - Fear of Recurrence - Concerns That Cancer May Come Back - Events That May Trigger Fear of Recurrence: Living with Continuing Uncertainty - Promoting Effective Health Care Communication - Making Informed Treatment Choices - Follow-Up Care - Tips for Coping with Fear of Recurrence - Balancing Reality with Stress Management Tips - Using Mind Body Techniques to Cope with Fear of Recurrence - How to Select the Mind Body Techniques That are Best for You - Communicating with Your Health Care Team About Quality-of-Life & Lifestyles Concerns - Guidelines for Preparing for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & OpenNotes Discussion - Questions for Our Panel of Experts

Send us a textEpisode #17 // Season:2025Our Founder & CEO, Luba Sasowski, celebrated a hard-fought win: the successful close of Bryght's 2020-2022 lawsuit. What makes this milestone even more powerful? Luba was undergoing treatment for Triple Negative Breast Cancer at the very same time.This throwback video captures her sitting down with our legal team sharing not only how we won, but also the lessons every small business needs to hear. Because the truth is, a lawsuit can happen to anyone.Three years later, this anniversary isn't just about surviving a case it's about thriving as a brand, staying resilient, and shining Bryghter than ever.  **The information provided in this video does not, and is not intended to, constitute legal advice or a contract; instead, all information, content, and materials available in this video are for general informational purposes only and based on publicly available information. Information in this video does not constitute the most up-to-date legal or other information. The video description may contain links to other third-party websites. Such links are only for the convenience of the viewer, user, or browser; Gelber Schachter & Greenberg, P.A., and its employees do not recommend or endorse the contents of any website. All opinions of Bryght are it's own and do not represent the opinions of Gelber Schachter & Greenberg, P.A.. **Support the show-----Our intro and outro music is made by Ashley from Lullaby The Fear Podcast. Listen to Lullaby here: https://lullabythefearpodcast.com/Special offer on Chippendale tickets! Use code BRYGHT25 for 25% off tickets to The Chippendales on Ticketmaster.Use code BRYGHT25 to get 25% OFF your tickets now!Sign up for Emails: https://promotions.lpage.co/campaigns/2789115See our trade show schedule: https://bryghtenup.com/pages/eventsFree online webinars: https://bryghtenup.com/pages/webinarStart Your Own Podcast for FREE With Buzzsprout Using Our Link and Get $20!! https://www.buzzsprout.com/?referrer_id=739373Follow us on social media @betweenbothcheekspodcastEmail us at podcast@bryghtenup.com

- American Society of Clinical Oncology (ASCO) 2025 Annual Meeting: Triple Negative Breast Cancer Updates - New Research on Triple Negative Breast Cancer Presented at ASCO - Triple Negative Breast Cancer-Specific Treatment Updates - Young Adults & Older Adult Updates - Updates on Clinical Trials in Advancing Treatment Choices - The Increasing Role of Diagnostic Testing, Biomarkers & Genetic Testing in Informing Treatment Options - Investigational New Therapies in Clinical Trials - New Developments in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Quality of Life & Pain - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Adherence, Follow-Up Care & Discussion of OpenNotes - Questions for Our Panel of Experts

- American Society of Clinical Oncology (ASCO) 2025 Annual Meeting: Triple Negative Breast Cancer Updates - New Research on Triple Negative Breast Cancer Presented at ASCO - Triple Negative Breast Cancer-Specific Treatment Updates - Young Adults & Older Adult Updates - Updates on Clinical Trials in Advancing Treatment Choices - The Increasing Role of Diagnostic Testing, Biomarkers & Genetic Testing in Informing Treatment Options - Investigational New Therapies in Clinical Trials - New Developments in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Quality of Life & Pain - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Adherence, Follow-Up Care & Discussion of OpenNotes - Questions for Our Panel of Experts

- American Society of Clinical Oncology (ASCO) 2025 Annual Meeting: Triple Negative Breast Cancer Updates - New Research on Triple Negative Breast Cancer Presented at ASCO - Triple Negative Breast Cancer-Specific Treatment Updates - Young Adults & Older Adult Updates - Updates on Clinical Trials in Advancing Treatment Choices - The Increasing Role of Diagnostic Testing, Biomarkers & Genetic Testing in Informing Treatment Options - Investigational New Therapies in Clinical Trials - New Developments in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Quality of Life & Pain - Key Questions to Ask Your Health Care Team - Guidelines for Preparing for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Adherence, Follow-Up Care & Discussion of OpenNotes - Questions for Our Panel of Experts

In today's episode, we had the opportunity to speak with Henry M. Kuerer, MD, PhD, FACS, CMQ, about the potential to safely omit surgery in a subset of patients with early-stage HER2-positive or triple-negative breast cancer who achieve a pathologic complete response (pCR) following neoadjuvant systemic therapy. Dr Kuerer is a professor of breast surgical oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. In our conversation, Dr Kuerer reviewed the rationale behind a prospective phase 2 clinical trial (NCT02945579) testing image-guided vacuum-assisted core biopsy to identify patients with no residual disease after neoadjuvant therapy. He outlined the strict technical and eligibility criteria that enabled accurate detection of pCR—including tumors downsizing to less than 2 cm and biopsy of at least 12 cores from the tumor bed—and discussed why this biopsy-based approach may be more reliable than standard surgery in detecting residual disease. He also highlighted the broader clinical implications of the findings, noting that patients with biopsy-confirmed pCR may proceed directly to radiotherapy and avoid breast surgery altogether.

Host Melissa Berry sits down with LaToya Bolds-Johnson — Physician Associate, triple negative breast cancer survivor, and passionate clinical trials advocate. With her experience as both a healthcare provider and a patient, Latoya offers a meaningful and insightful perspective on clinical trials and how they can transform cancer treatment. In this episode, LaToya shares her personal journey navigating breast cancer treatment and the challenges of finding the right clinical trial. They discuss the critical need for greater diversity in clinical trial participation, and how her involvement created a “medical trust fund” for her daughters' futures. LaToya also discusses how we can shift the mindset around clinical trials from being seen as a last resort to a standard of care, helping patients advocate for themselves and make informed choices. If you're newly diagnosed, considering treatment options, or want to learn how clinical trials can offer hope and opportunity, this episode is a must-listen!  

Host Melissa Berry sits down with Melissa Eppard, a triple negative breast cancer survivor and co-founder of Upstate Mary, a wellness brand focused on CBD-infused intimacy products. They talk about Melissa's personal breast cancer experience and the challenges many patients face with intimacy during and after treatment. Their conversation highlights the importance of addressing issues like vaginal dryness and the need for lubrication, which are often misunderstood, overlooked, and surrounded by shame. Melissa shares how CBD can help improve comfort and sexual wellness, while normalizing these conversations and taking the shame away. They also discuss the pressures both cancer survivors as well as their partners can feel around intimacy and the power of community support in reclaiming confidence and connection after cancer. This episode offers honest insights and encourages open conversations about sexual health for cancer survivors and their partners.

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.  CME information and select publications here.

Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics: Introduction (0:00) HER2-Positive Breast Cancer — Dr O'Shaughnessy (3:13) Triple-Negative Breast Cancer — Dr Bardia (32:56) Personalizing Adjuvant Therapy for Patients with HR-Positive Breast Cancer — Dr Borges (57:35) Current Role of CDK4/6 Inhibitors in the Localized Setting — Dr Burstein (1:25:15) CME information and select publications

It's been known for many years that Black women are twice as likely as white women to be diagnosed with triple-negative breast cancer. If diagnosed with this type of breast cancer, Black women are also more than twice as likely to die from the disease than women of other races and ethnicities. Researchers have been studying a number of factors that may play a role in these disparities. Dr. Sanchita Bhatnagar's research has found that cells that have too much TRIM37 protein are much more likely to become cancerous. She and her colleagues also have found that the breast tissue of Black women are much more likely to have high levels of TRIM37. Listen to the episode to hear Dr. Bhatnagar explain: how she began studying the TRIM37 gene how a variant in the TRIM37 gene that causes more of the TRIM37 protein to be made is more common in Black women that white women how a medicine that targets the TRIM37 protein could help stop triple-negative breast cancer from metastasizing next steps for her research

In this special episode, I sit down with Ricki Fairley of TOUCH, The Black Breast Cancer Alliance and Hayley Dinerman of the Triple Negative Breast Cancer Foundation to discuss the latest advancements in TNBC research, including key takeaways from SABCS 2024, new immunotherapy and targeted therapies, and the impact of the AACR research grant. We also explore efforts to address racial disparities, upcoming awareness initiatives, and how you can get involved. Don't miss this insightful conversation about the future of TNBC treatment and advocacy. Thank you to Merck, Daiichi-Sankyo, Gilead, Pfizer, and Lilly for making this episode possible!  

Dinah McClymonds shares her journey with triple negative breast cancer and how regular mammograms detected her condition. She elaborates on her 2016 diagnosis and subsequent chemotherapy, surgery, and radiation, until she completed treatment a year later. Dinah had a positive experience with the medical care she received but acknowledges that many women lack such access. Her conversation with Dorothy highlights that early detection can significantly impact outcomes, even for those without a family history of the disease. She stresses the importance of mammograms and the need for broader access to these screenings, especially for uninsured women. Dinah also touches on her role as the chair for the 2025 Everything’s Coming Up Roses Luncheon supporting The Rose. Her background in fundraising and volunteering shapes her efforts to increase awareness and resources for those in need. Subscribe to Let’s Talk About Your Breasts wherever you get your podcasts and consider making a donation at therose.org. Key Questions Answered 1.) What prompted Dinah McClymonds to discuss breast cancer treatment and medical care? 2.) When and how was Dinah McClymonds's breast cancer diagnosed? 3.) How did her age and ethnicity influence her breast cancer treatment and prognosis? 4.) Did Dinah inform her family about her diagnosis, and how did genetic testing play a role for her identical twin? 5.) What is Dinah's message regarding early breast cancer detection and access to treatment? Timestamped Overview 00:00 Dinah to chair 2025 breast cancer luncheon. 03:33 Involvement in volunteer work with Kappa Alpha Theta. 09:06 Access to breast cancer treatment varies widely. 10:39 Challenging cancer diagnosis disrupts vacation plans. 14:06 Mammogram detected breast cancer, no symptoms noticed. 18:00 Unexplained triple negative, not hormonal, just fluke. 21:59 Effects of breast cancer treatment on body. 23:43 Accepting aging and medical treatment's inevitable impact. 29:04 Supporting access to early cancer detection and treatment. 30:11 Thank you for being our chair today.See omnystudio.com/listener for privacy information.

A young mom discovers a lump and learns she has triple negative breast cancer. She shares her journey and the supports she found from family, friends and faith.

It is Triple Negative Breast Cancer Day – an annual opportunity to bring more awareness to this aggressive type of breast cancer that is difficult to treat because it lacks an estrogen, progesterone and HER2 receptor. It primarily affects younger women and Black women and can spread quickly and be deadly if left untreated for too long. Treatment for TNBC used to include the toughest forms of chemotherapy, with debilitating side effects – but we've come a long way in how we treat patients with Triple Negative Breast Cancer so their outcomes are better. Today, we are speaking with Dr. Heather McArthur of UT Southwestern. She is a former Susan G. Komen grantee, Professor and the Komen Distinguished Chair in Clinical Breast Cancer Research. Dr. McArthur has been working on a Phase 3 clinical trial called KEYNOTE-522, which is testing whether a specific immunotherapy drug improves overall survival for people with high-risk early Triple Negative Breast Cancer. Dr. McArthur, along with her colleagues, are trying to determine if all people with this type of breast cancer truly need the drug, and if not, who would most benefit from taking it.

Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Virginia Kaklamani from the UTHealth San Antonio MD Anderson Cancer Center to discuss the latest advances in the treatment of triple negative breast cancer (TNBC) as we kick off 2025. •⁠  ⁠The treatment paradigms for early-stage TNBC, including the role Sacituzumab and radiation therapy. •⁠  ⁠Insights from the SABCS 2024 conference, focusing on the keynote 522 regimen and its implications for neoadjuvant treatment. •⁠  ⁠The management of locally advanced and metastatic TNBC, including the use of immunotherapy and the importance of PD-L1 testing. •⁠  ⁠Strategies for managing toxicities associated with treatments like sacituzumab and T-DXd. Whether you're a healthcare professional or someone interested in the latest in oncology, this episode provides valuable insights into the evolving landscape of breast cancer treatment. Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers! Key Takeaways: •⁠  ⁠Current standard of care for locally advanced TNBC. •⁠  ⁠The significance of chemotherapy and immunotherapy in treatment plans. •⁠  ⁠Managing toxicities in metastatic disease. Stay tuned for more discussions on treatment algorithms, FDA approvals, and clinical pearls in oncology! YouTube: https://youtu.be/GfROoYPVb_8 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers